North American Life Science Sector Wraps Up Construction on 69 Projects Topping $3 Billion in Second-Quarter 2013

SUGAR LAND--June 25, 2013--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--With 2013 almost half over, the Life Science sector is busy finishing out an impressive array of capital construction projects. As the second quarter enters its final days, the Life Science sector is on target to complete construction on a total of 69 North American capital projects, each as diverse as the industry itself. A recent survey of reported projects in Industrial Info's Pharmaceutical Tracker - Online Database reveals that the projects represent a total investment value (TIV) of $3.2 billion.

Other companies featured: Gilead Sciences (NASDAQ:GILD), St. Jude Medical (NYSE:STJ)